Dermapharm Holding SE (DMP) NPV (Bearer Shares)

Sell:€38.90Buy:€39.75€0.35 (0.92%)

Prices delayed by at least 15 minutes
Sell:€38.90
Buy:€39.75
Change:€0.35 (0.92%)
Prices delayed by at least 15 minutes
Sell:€38.90
Buy:€39.75
Change:€0.35 (0.92%)
Prices delayed by at least 15 minutes

Company Information

About this company

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.

Key people

Wilhelm Beier
Chairman of the Supervisory Board
Hans-Georg Feldmeier
Chairman of the Management Board, Chief Executive Officer
Erwin Kern
Independent Deputy Chairman of the Supervisory Board
Christof Dreibholz
Chief Financial Officer, Chief Compliance Officer, Member of the Management Board
Andreas Eberhorn
Chief Marketing Officer, Member of the Management Board
Lothar Lanz
Independent Member of the Supervisory Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Germany
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    DE000A2GS5D8
  • Market cap
    €2.09bn
  • Employees
    3,603
  • Shares in issue
    53.84m
  • Exchange
    XETRA
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.